
Sun Pharma Q4 revenue nears ₹13000 cr, weak US sales drags down net profit
Mumbai: Indian pharma major Sun Pharma Q4 FY2024-25 total revenue from operation reported an year-on-year (YoY) increase of 8 per cent to ₹12,958 crore, up from ₹11,982 crore of the previous fiscal. The net profit for the period stood at ₹2,153 crore, …